ReShape Lifesciences Inc. (NASDAQ: RSLS)
$0.24
+0.0073 ( +3.21% ) 876.7K
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Data
Open
$0.24
Previous close
$0.23
Volume
876.7K
Market cap
$5.49M
Day range
$0.21 - $0.24
52 week range
$0.14 - $1.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 1 | Jan 16, 2024 |
pre | Proxies and info statements | 4 | Jan 05, 2024 |
8-k | 8K-related | 15 | Nov 29, 2023 |
10-q | Quarterly Reports | 62 | Nov 09, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
4 | Insider transactions | 1 | Nov 08, 2023 |
8-k | 8K-related | 12 | Oct 13, 2023 |
8-k | 8K-related | 14 | Oct 05, 2023 |
8-k | 8K-related | 14 | Sep 22, 2023 |
8-k | 8K-related | 15 | Aug 07, 2023 |